Susquehanna International Group, LLP Vericel Corp Transaction History

Susquehanna International Group, LLP

  • $823 Billion
  • Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Vericel Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 6,842 shares of VCEL stock, worth $272,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,842
Previous 62,459 89.05%
Holding current value
$272,722
Previous $2.66 Million 91.91%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$29.84 - $41.74 $1.66 Million - $2.32 Million
-55,617 Reduced 89.05%
6,842 $215,000
Q2 2025

Aug 14, 2025
SELL
$37.92 - $45.7 $272,758 - $328,720
-7,193 Reduced 10.33%
62,459 $2.66 Million
Q1 2025

May 14, 2025
BUY
$44.5 - $61.8 $1.98 Million - $2.75 Million
44,507 Added 177.0%
69,652 $3.11 Million
Q4 2024

Feb 14, 2025
SELL
$40.05 - $59.11 $359,088 - $529,980
-8,966 Reduced 26.28%
25,145 $1.38 Million
Q3 2024

Nov 14, 2024
BUY
$42.25 - $53.56 $467,200 - $592,266
11,058 Added 47.97%
34,111 $1.44 Million
Q2 2024

Aug 15, 2024
SELL
$41.71 - $52.9 $743,355 - $942,783
-17,822 Reduced 43.6%
23,053 $1.06 Million
Q1 2024

May 07, 2024
BUY
$32.52 - $52.33 $740,610 - $1.19 Million
22,774 Added 125.82%
40,875 $2.13 Million
Q4 2023

Feb 14, 2024
SELL
$30.85 - $37.09 $1.66 Million - $1.99 Million
-53,766 Reduced 74.81%
18,101 $644,000
Q3 2023

Nov 14, 2023
BUY
$31.69 - $39.25 $413,966 - $512,722
13,063 Added 22.21%
71,867 $2.41 Million
Q2 2023

Aug 11, 2023
SELL
$29.0 - $38.37 $733,236 - $970,147
-25,284 Reduced 30.07%
58,804 $2.21 Million
Q1 2023

May 16, 2023
BUY
$23.85 - $31.34 $1.67 Million - $2.2 Million
70,059 Added 499.39%
84,088 $2.47 Million
Q4 2022

Feb 14, 2023
SELL
$17.65 - $27.37 $691,897 - $1.07 Million
-39,201 Reduced 73.64%
14,029 $369,000
Q3 2022

Nov 14, 2022
BUY
$22.62 - $32.54 $565,047 - $812,849
24,980 Added 88.42%
53,230 $1.24 Million
Q2 2022

Aug 15, 2022
SELL
$22.88 - $39.45 $578,932 - $998,203
-25,303 Reduced 47.25%
28,250 $711,000
Q1 2022

May 16, 2022
SELL
$31.69 - $43.29 $23,862 - $32,597
-753 Reduced 1.39%
53,553 $2.05 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $52.6 $119,468 - $178,524
3,394 Added 6.67%
54,306 $2.13 Million
Q3 2021

Nov 15, 2021
BUY
$46.35 - $59.75 $972,237 - $1.25 Million
20,976 Added 70.07%
50,912 $2.49 Million
Q2 2021

Aug 11, 2021
BUY
$47.2 - $67.81 $615,252 - $883,903
13,035 Added 77.13%
29,936 $1.57 Million
Q1 2021

May 17, 2021
BUY
$30.93 - $59.48 $155,825 - $299,660
5,038 Added 42.47%
16,901 $939,000
Q4 2020

Feb 16, 2021
SELL
$18.53 - $31.5 $356,498 - $606,028
-19,239 Reduced 61.86%
11,863 $366,000
Q1 2020

May 15, 2020
BUY
$7.25 - $19.22 $105,009 - $278,382
14,484 Added 87.16%
31,102 $285,000
Q4 2019

Feb 14, 2020
SELL
$13.77 - $19.2 $428,274 - $597,158
-31,102 Reduced 65.18%
16,618 $289,000
Q3 2019

Nov 14, 2019
SELL
$14.93 - $19.83 $154,734 - $205,518
-10,364 Reduced 17.84%
47,720 $722,000
Q2 2019

Aug 16, 2019
BUY
$15.01 - $18.89 $159,226 - $200,385
10,608 Added 22.34%
58,084 $1.1 Million
Q2 2019

Aug 14, 2019
SELL
$15.01 - $18.89 $755,888 - $951,281
-50,359 Reduced 51.47%
47,476 $897,000
Q2 2018

Aug 14, 2018
SELL
$9.6 - $14.6 $1.99 Million - $3.02 Million
-207,172 Reduced 67.92%
97,835 $949,000
Q1 2018

May 15, 2018
BUY
$5.7 - $12.3 $1.31 Million - $2.83 Million
230,033 Added 306.82%
305,007 $3.04 Million
Q4 2017

Feb 14, 2018
BUY
$3.65 - $5.98 $193,223 - $316,569
52,938 Added 240.23%
74,974 $409,000
Q3 2017

Nov 14, 2017
BUY
$3.0 - $6.0 $66,108 - $132,216
22,036
22,036 $132,000

Others Institutions Holding VCEL

# of Institutions
274
Shares Held
52.6M
Call Options Held
36.6K
Put Options Held
9.1K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email